INCB054828 (pemigatinib), a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays activity against genetically defined tumor models

Phillip C.C. Liu(Incyte (United States)), Gregory Hollis(Incyte (United States))

PLoS ONE

April 21, 2020

10.1371/journal.pone.0231877

Cited by 160

Related Papers

Combined Inhibition of Janus Kinase 1/2 for the Treatment of JAK2V617F-Driven Neoplasms: Selective Effects on Mutant Cells and Improvements in Measures of Disease Severity

|Clinical Cancer Research|2009|19